Ureteroscope Market - Size & Forecast

Ureteroscope Market Data Product Overview

The Ureteroscope Market data product covers market sizing, growth trends, segmentation, regional analysis, competitive developments, and company profiling across the ureteroscopy industry. The market is projected to reach USD 2.19 billion by 2030, with a 5.8% CAGR from 2025–2030. Coverage includes flexible, semi-rigid, and rigid ureteroscopes; reusable and disposable/single-use usage models; therapeutic and diagnostic procedures; applications including urolithiasis and ureteral strictures; and end users such as hospitals, urology clinics, and ambulatory surgical centers. The research combines primary interviews with industry experts and secondary research from proprietary databases.

Use Cases

• Market entry sizing: Assess the market trajectory from USD 1.65 billion in 2025 to USD 2.19 billion by 2030 and evaluate demand linked to kidney stone prevalence and minimally invasive procedures.

• Competitive benchmarking: Compare strategic developments among key players including Boston Scientific, Olympus, Stryker, and Dornier MedTech, alongside product and technology developments.

• M&A target screening: Review market activity, portfolio expansion, acquisitions, and technology developments relevant to urology and minimally invasive care.

• Vendor evaluation: Compare product and application opportunities across flexible, semi-rigid, rigid, reusable, and single-use ureteroscope segments and outpatient surgical-center demand.

Metadata

• Update Frequency: One-time syndicated market research product.

• Data Source(s): Primary interviews with industry experts plus secondary research from proprietary databases and industry sources. The market figures are aggregated research estimates rather than individually attributable observations.

• Original Publisher of data: Next Move Strategy Consulting.

• Geographic coverage: North America, Europe, Asia-Pacific, and Rest of World, with regional and country-level analysis where covered in the report.

• Is historical data "point-in-time": Historical figures are point-in-time estimates as of publication; forecast years are projections.

• Data Set(s) Format(s): PDF / Excel.

• Raw or scraped data: No syndicated analyst research.

• Number of companies/brands covered: 15 Companies.

Key Data Points

• Rising prevalence of kidney stones: Increasing urolithiasis incidence, linked in the report to factors including sedentary lifestyles, inadequate hydration, high-sodium diets, and rising obesity, is supporting demand for ureteroscopy.

• Adoption of minimally invasive procedures: Demand is supported by preference for ureteroscopy because of its minimally invasive nature, lower complication risk, shorter recovery periods, and reduced postoperative discomfort.

• Technological advancements: High-definition digital imaging, enhanced flexibility, single-use ureteroscopes, robotic-assisted procedures, and medical laser technologies are contributing to procedural efficiency and market development.

Pricing Information

Pricing is provided through the AWS Data Exchange offer. Where multiple license tiers are available, subscribers should review the applicable AWS offer terms for tier-specific pricing.

Regulatory and Compliance Information

This report is built from aggregated, publicly available, and licensed secondary sources plus expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data.

Subscription Verification

AWS Data Exchange requires subscription verification on public offers. Subscribers confirm their eligibility under applicable AWS restrictions and covered-party requirements.